Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by 90Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma
Crossref DOI link: https://doi.org/10.1186/s40164-015-0012-3
Published Online: 2015-06-24
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pisani, Francesco
Sciuto, Rosa
Dessanti, Maria Laura
Giannarelli, Diana
Kayal, Ramy
Rea, Sandra
Marchesi, Francesco
Marino, Mirella
License valid from 2015-06-24
Article History
Received: 20 March 2015
Accepted: 17 June 2015
First Online: 24 June 2015